Thompson T - Search Results

1

Optimal allocation of resources across four interventions for type 2 diabetes.

Earnshaw SR, Richter A, Sorensen SW, Hoerger TJ, Hicks KA, Engelgau M, Thompson T, Narayan KM, Williamson DF, Gregg E, Zhang P. Earnshaw SR, et al. Among authors: thompson t. Med Decis Making. 2002 Sep-Oct;22(5 Suppl):S80-91. doi: 10.1177/027298902237704. Med Decis Making. 2002. PMID: 12369234

2

A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050.

Honeycutt AA, Boyle JP, Broglio KR, Thompson TJ, Hoerger TJ, Geiss LS, Narayan KM. Honeycutt AA, et al. Health Care Manag Sci. 2003 Aug;6(3):155-64. doi: 10.1023/a:1024467522972. Health Care Manag Sci. 2003. PMID: 12943151

3

Lifetime risk for diabetes mellitus in the United States.

Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Narayan KM, et al. JAMA. 2003 Oct 8;290(14):1884-90. doi: 10.1001/jama.290.14.1884. JAMA. 2003. PMID: 14532317

4

A diabetes report card for the United States: quality of care in the 1990s.

Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM. Saaddine JB, et al. Ann Intern Med. 2002 Apr 16;136(8):565-74. doi: 10.7326/0003-4819-136-8-200204160-00005. Ann Intern Med. 2002. PMID: 11955024 Free article.

5

Cost effectiveness of ACE inhibitor treatment for patients with type 1 diabetes mellitus.

Dong FB, Sorensen SW, Manninen DL, Thompson TJ, Narayan V, Orians CE, Gregg EW, Eastman RC, Dasbach EJ, Herman WH, Newman JM, Narva AS, Ballard DJ, Engelgau MM. Dong FB, et al. Pharmacoeconomics. 2004;22(15):1015-27. doi: 10.2165/00019053-200422150-00005. Pharmacoeconomics. 2004. PMID: 15449965

6

The use of population attributable risk to estimate the impact of prevention and early detection of type 2 diabetes on population-wide mortality risk in US males.

Narayan KM, Thompson TJ, Boyle JP, Beckles GL, Engelgau MM, Vinicor F, Williamson DF. Narayan KM, et al. Among authors: thompson tj. Health Care Manag Sci. 1999 Dec;2(4):223-7. doi: 10.1023/a:1019048114376. Health Care Manag Sci. 1999. PMID: 10994488

7

Effect of BMI on lifetime risk for diabetes in the U.S.

Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF. Narayan KM, et al. Diabetes Care. 2007 Jun;30(6):1562-6. doi: 10.2337/dc06-2544. Epub 2007 Mar 19. Diabetes Care. 2007. PMID: 17372155

8

Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985-2011: a modelling study.

Gregg EW, Zhuo X, Cheng YJ, Albright AL, Narayan KM, Thompson TJ. Gregg EW, et al. Lancet Diabetes Endocrinol. 2014 Nov;2(11):867-74. doi: 10.1016/S2213-8587(14)70161-5. Epub 2014 Aug 12. Lancet Diabetes Endocrinol. 2014. PMID: 25128274

9

The lifetime cost of diabetes and its implications for diabetes prevention.

Zhuo X, Zhang P, Barker L, Albright A, Thompson TJ, Gregg E. Zhuo X, et al. Diabetes Care. 2014 Sep;37(9):2557-64. doi: 10.2337/dc13-2484. Diabetes Care. 2014. PMID: 25147254

10

The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976-2004.

Gregg EW, Cheng YJ, Narayan KM, Thompson TJ, Williamson DF. Gregg EW, et al. Prev Med. 2007 Nov;45(5):348-52. doi: 10.1016/j.ypmed.2007.07.020. Epub 2007 Jul 26. Prev Med. 2007. PMID: 17889292

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,714 results

Search Page

Filters